Cryofibrinogenaemia: A study of 49 patients

Clinical and Experimental Immunology

Volumn 120, Issue 2, 2000, Pages 253-260

  Blain, H ^a   Cacoub, Patrice ^a   Musset, L ^a   Costedoat Chalumeau, N ^a   Silberstein, C ^a   Chosidow, O ^a   Godeau, P ^a   Frances, C ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cryofibrinogen; Cryofibrinogenaemia; Cryoglobulinaemia

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; CRYOFIBRINOGEN; CRYOGLOBULIN; FIBRINOGEN; FIBRONECTIN; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; BLOOD DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYOFIBRINOGENEMIA; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; NEPHELOMETRY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HUMANS; MALE; MIDDLE AGED;

EID: 0034075456     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01210.x     Document Type: Article

References (33)

1. 1 Korst DR, Kratochvil CH. 'Cryofibrinogen' in a case of lung neoplasm associated with thrombophlebitis migrans. Blood 1955; 10:945-53.
2. 2 Stathakis NE, Karamanolis D, Koukoulis G, Tsianos E. Characterization of cryofibrinogen isolated from patient's plasma. Haemostasis 1981; 10:195-202.
3. 3 Rachmilewitz EA, Sacks MI, Zlotnick A. Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci 1970; 6:32-43.
4. 4 Beightler E, Diven DG, Sanchez RL, Solomon AR. Thrombotic vasculopathy associated with cryofibrinogenemia. J Am Acad Dermatol 1991; 24:342-5.
5. 5 Jantunen E, Soppi E, Neittaanmäki H, Lahtinen R. Essential cryofibrinogenaemia, leukocytoclastic vasculitis and chronic purpura. J Int Med 1993; 234:331-3.
6. 6 McKee PA, Kalbfleisch JM, Bird RM. Incidence and significance of cryofibrinogenemia. J Lab Clin Med 1963; 61:203-10.
7. 7 Zlotnick A, Shahin W, Rachmilewitz EA. Studies in cryofibrinogenemia. Acta Haematol 1969; 42:8-17.
8. 8 Smith SB, Arkin C. Cryofibrinogenemia. Incidence, clinical correlations, and a review of the literature. Am J Clin Pathol 1972; 58:524-30.
9. 9 Moroz LA, Rose B. The cryopathies. In: Samter M, ed. Immunological diseases. Boston: Little, Brown, 1978:570-91.
10. 10 Robinson MG, Troiano G, Cohen H et al. Acute transient cryofibrinogenemia in infants. J Pediatr 1966; 69:35-39.
11. 11 Ritzmann SE, Levin WC, Ivers JB, Koch JL. 1. Cryoproteinemias. 2. Primary cryofibrinogenemia. Its association with cryopathy and telangiectasis. Tex Rep Biol Med 1963; 21:567-80.
12. 12 Ireland TA, Werner DA, Rietschel RL, Patterson JH, Spraker MK. Cutaneous lesions in cryofibrinogenemia. J Pediatr 1984; 10:67-70.
13. 13 Nagy J, Ambrus M, Paal M, Trinn C, Burger T. Cryoglobulinaemia and cryofibrinogenaemia in IgA nephropathy: a follow-up study. Nephron 1987; 46:337-42.
14. 14 Brungger A, Brulisauer M, Mitsuhashi Y, Schneider BV, Bollinger A, Schnyder UW. Cryofibrinogenemic purpura. Arch Dermatol Res 1987; 279:S24-29.
15. 15 Griswold WR, Simon G, McIntosh RM. Anaphylactoid purpura, cold exposure, and cryofibrinogenemia. Ann Intern Med 1973; 78:611.
16. 16 Barrett MC, Prendiville JS, Pardy BJ, Cream JJ. Cryofibrinogenaemia and acute gangrene in systemic sclerosis. Postgr Med J 1986; 62:935-6.
17. 17 Musset L, Diemert MC, Taibi F et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38:798-802.
18. 18 Von Clauss A. Gerinnungsphysiologische Schnellmethod zur Bestimmung des Fibrinogens. Acta Haematol (Basel) 1957; 17:237-46.
19. 19 Kellett J. Thyrotoxicosis, cryofibrinogenemia, sinutab maximum strength, and purple ears. Ann Intern Med 1989; 110:668(letter).
20. 20 Rubegni P, Flori ML, Fimiani M, Andreassi L. A case of cryofibrinogenemia responsive to stanozolol. Br J Haematol 1996; 93:217-9.
21. 21 Williamson AE, Cone LA, Il SH, Mirage R. Spontaneous necrosis of the skin associated with cryofibrinogenemia, cryoglobulinemia, and homocystinuria. Ann Vasc Surg 1996; 10:365-9.
22. 22 Jager BV. Cryofibrinogenemia. N Engl J Med 1972; 266:579-83.
23. 23 Martin S. Cryofibrinogenemia, monoclonal gammopathy, and purpura. Arch Dermatol 1979; 115:208-11.
24. 24 Kuipers JG, Kellett J, May D. Low levels of cryofibrinogenaemia and peripheral circulatory dysfunction. Ir Med J 1991; 84:68-69.
25. 25 Ayres ML, Jarrett PEM, Browse NL. Blood viscosity, Raynaud's phenomenon and the effect of fibrinolytic enhancement. BJS 1981; 68:51-54.
26. 26 Kluft C, Preston FE, Malia RG et al. Stanozolol induced changes in fibrinolysis and coagulation in healthy adults. Throm Haemost 1984; 51:157-64.
27. 27 Klein AD, Kerdel FA. Purpura and recurrent ulcers on the lower extremities. Essential cryofibrinogenemia. Arch Dermatol 1991; 127:113-8.
28. 28 Falanga V, Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet 1991; 338:347-8.
29. 29 Wulffraat N, Meyer JT, Zegers BJM, Kuis W. Familial presence of primary cryofibrinogenemia. A report of three cases. Br J Rhumatol 1996; 35:102-4.
30. 30 Watanabe R, Iijima M, Otsuka F. A case of neutrophilic dermatosis (ND) complicated by cryofibrinogenemia (CFGN) and myelodysplastic syndrome (MDS). J Dermatol 1992; 19:181-5.
31. 31 Strevey J, Beaulieu AD, Menard C, Valet JP, Latulippe L, Hebert J. The role of fibronectin in the precipitation of monoclonal cryoglobulins. Clin Exp Immunol 1984; 55:340-5.
32. 32 Brandau DT, O'Donnell R, Kimmel-Truitt VL. Lack of binding between cryoimmunoglobulins, immunoglobulins and fibronectin: implication for immune complex vasculitis. Clin Exp Immunol 1991; 83:58-63.
33. 33 Copeman PW. Cryofibrinogenaemia and skin ulcers: treatment with plasmapheresis. Br J Dermatol 1979; 101:57-58.